Shaily Engineering Plastics Ltd
Shaily Engineering Plastics Q1 FY26 earnings call: Revenue & Margins
Q1 FY26 earnings call: what management said on revenue, margins and capex.
Guidance rank: #55 of 84 in Consumer Durables
See the sector's top 10 — free with your mobile number.
Shaily Engineering Plastics Ltd Q1 FY26 key numbers
- Revenue
- Capacity expansion: Current effective pen manufacturing capacity to reach 70-75 million pens by FY '27, targeting 80-85% utilization.
As stated in Shaily Engineering Plastics Ltd's Q1 FY26 earnings call transcript · published 7 Aug 2026. Reported figures, not investment advice.
The short version
The Healthcare segment is expected to contribute significantly to revenue and profitability over the next couple of years. Healthcare segment revenue grew 181% YoY in Q1 FY '26, driving overall strong revenue growth of 38% YoY.
From Shaily Engineering Plastics Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- The Healthcare segment is expected to contribute significantly to revenue and profitability over the next couple of years.
- Capacity expansion: Current effective pen manufacturing capacity to reach 70-75 million pens by FY '27, targeting 80-85% utilization.
- Full utilization of expanded capacity by FY '28 is the target, contingent on product launches and customer approvals.
- Significant growth anticipated from IP-led pen platforms, especially GLP-1 pens like semaglutide.
- Ongoing discussions with multiple customers for volume commitments and capacity over next 3-5 years.
- Continued investment in new technologies and innovations aiming at breakthrough drug delivery devices.
2 more points from Shaily Engineering Plastics Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Shaily Engineering Plastics Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- INR125 crores capex planned over the next 12 to 18 months for expanding pen manufacturing capacity by 50 million units in two phases of 25 million each (Q2 FY ‘26 and Q1 FY ‘27).
- Additional capacity expansion to reach an effective capacity of 70-75 million pens by early FY ’27.
- No additional land required for current capex; expansions conducted on existing plant or new greenfield sites.
- Focus on scaling up IP-led pen platforms, including new variants like semaglutide pens.
- Strategic investments aligned with volume commitments from customers over the next 3 to 5 years.
2 more points from Shaily Engineering Plastics Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Consumer Durables
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Shaily Engineering Plastics Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Current capacity of 70 to 75 million pens (80-85% utilization) is based on customer commitments, with about 50-60% backed by firm take-or-pay contracts.
- Capacity expansions aligned with signed contracts; further expansions will depend on new capacity contracts.
- Discussions ongoing with multiple customers regarding volume commitments and capacity requirements for next 3-5 years.
- Customers are negotiating increased capacity and buffer volumes to cater to potential market upside.
- The orderbook visibility depends heavily on product launch timings and approvals; hence exact numbers are fluid.
- No advances for capex are taken from customers; agreements are volume-based supply commitments.
2 more points from Shaily Engineering Plastics Ltd's call on order book
Create a free account to keep reading this call
Shaily Engineering Plastics Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹310 Cr, net profit ₹67 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Shaily Engineering Plastics Ltd's management said in earlier quarters
- Q2 FY27 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
Others in Consumer Durables this season
- T B Z (Q1 FY26)
Revenue from operations for Q1 FY26: ₹6,240.07 million, up 4.66% YoY from ₹5,962.43 million in Q1 FY25 (Page 8, Page 7). Key concall takeaways from…
- Stylam Industrie (Q1 FY26)
Quarterly Sales Performance (₹ crores): . Key concall takeaways from Stylam Industries Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.
- KDDL Ltd (Q1 FY26)
465.0 Cr, up 29.2% YoY from Rs. Key concall takeaways from KDDL Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.
- Ethos (Q1 FY26)
Revenue from operations in Q1 FY26: ₹346.3 crore, up 26.7% YoY from ₹273.2 crore in Q1 FY25 (Page 11, 12). Key concall takeaways from Ethos Ltd's Q1 FY26…
Potential multibaggers · Q2 FY27
Potential multibaggers in Consumer Durables
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Shaily Engineering Plastics Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Shaily Engineering Plastics Ltd Q1 FY26 results?
The Healthcare segment is expected to contribute significantly to revenue and profitability over the next couple of years. Healthcare segment revenue grew 181% YoY in Q1 FY '26, driving overall strong revenue growth of 38% YoY.
What is Shaily Engineering Plastics Ltd share price analysis?
Shaily Engineering Plastics Ltd currently shows a neutral. The stock trades at a P/E of 90.6 with a market cap of ₹14,609 Cr. Investors should review the full earnings analysis for detailed insights.
Is Shaily Engineering Plastics Ltd planning capital expenditure?
INR125 crores capex planned over the next 12 to 18 months for expanding pen manufacturing capacity by 50 million units in two phases of 25 million each (Q2 FY ‘26 and Q1 FY ‘27).
Keep Shaily Engineering Plastics Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.